A time-dependent inhibition of the thyrotropin-releasing-hormone (TRH)-degrading ectoenzyme from rat brain by the metal-complexing agents imidazole, NaCN, EDTA and 1,10-phenanthroline could be demonstrated. In contrast, the inhibition by the non-chelating analogues 4,7-and 1,7-phenanthroline was not time-dependent. At a concentration of 100 ,M EDTA the enzymic activity decreased by 50 % only after pretreatment for 6 h.
INTRODUCTION
Thyrotropin-releasing hormone (TRH; pyroGlu-His-Pro-NH2), the first hypothalamic hypophysiotrophic neuropeptide hormone to be structurally elucidated, stimulates thyrotropin, prolactin and, in certain cases, growth hormone secretion [1, 2] . In addition to these endocrine functions, TRH elicits a variety of behavioural changes and neuropharmacological effects [3, 4] , suggesting that TRH may be involved in neurotransmission or other forms of cellular communication. This hypothesis is supported by the observation that TRH is widely distributed in extra-hypothalamic brain areas [5] [6] [7] and that high-affinity receptors for TRH are found throughout the central nervous system [8, 9] . In addition, biochemical studies suggest that TRH signals might be terminated by a particulate enzyme hydrolysing TRH at the pyroGlu-His bond.
The particulate TRH-degrading enzyme is located in synaptosomal [10] and adenohypophyseal [11] membranes with its active site oriented towards the extracellular space [12] [13] [14] and thus represents a true ectoenzyme. In addition, the observations that relatively high enzymic activities are associated with neuronal cells while only low activities are found in pituitary aggregates and glial cells are almost devoid of it indicated that this enzyme is not a general constituent of plasma membranes, thereby suggesting that it may serve very specialized functions for the inactivation of TRH after its release. This interpretation is supported by the observation that the activity of the adenohypophyseal ectoenzyme is stringently controlled by oestradiol and thyroid hormones [15] [16] [17] [18] , whereas the activity of the brain enzyme is not [15, 19] . Furthermore, and most importantly, the TRH-degrading ectoenzyme exhibits a very high degree of substrate specificity [20] like the TRH-degrading serum enzyme studied before [21] . The biochemical data presently available strongly indicate that the TRH-degrading ectoenzyme and the serum enzyme may be derived from the same gene since they Mn2+, as well as by Ca2+ and Mg2+. Compatible with the HisGlu-Xaa-Xaa-His consensus sequence of most zinc-containing metallopeptidases, chemical modification studies with carbodiimide revealed the presence of an essential acidic amino acid residue, probably located at the active site of the enzyme. The catalytically active metal ion could be exchanged for f5Zn and the enzyme could be effectively inhibited by L-pyroglutamyl hydroxamic acid, the chelating derivative of the TRH cleavage product pyroglutamic acid. The TRH-degrading ectoenzyme thus classifies as a member of the zinc-dependent metallopeptidase family.
share many similarities with respect to pH optimum, sensitivity to inhibitors, etc. [22] . Previous studies by various investigators clearly demonstrated that these enzymes are insensitive towards serine-and cysteine-specific reagents or peptidic inhibitors of aspartic proteases, but are sensitive towards the chelating reagents EDTA and 1,10-phenanthroline [10, [23] [24] [25] [26] . Therefore it is widely assumed that these enzymes are metallopeptidases. However, significant inhibition of the TRH-degrading ectoenzyme and the TRH-degrading enzyme in serum was only observed when EDTA was added in millimolar concentrations (and even at these high concentrations the reported values differ considerably), while extensively characterized metalloproteases such as neutral endopeptidase or angiotensin-converting enzyme are effectively inhibited by micromolar concentrations of EDTA [27] [28] [29] . Strong inhibition of the TRH-degrading ectoenzyme by 1,10-phenanthroline was observed by all investigators, but appropriate controls with non-chelating isomers of this compound had not been performed. In addition, it had not been demonstrated that inhibition of the enzymic activity could be reversed by addition of metal ions. Furthermore, while the active site of most metalloproteases contains glutamic acid, the recently reported study on the chemical modification of the TRH-degrading ectoenzyme failed to identify glutamic acid as a catalytically essential residue [30] .
We decided to re-investigate the catalytic mechanism of the TRH-degrading ectoenzyme and report here that it is indeed a metalloenzyme, albeit one which exhibits some unusual properties. 
MATERIALS AND

Enzyme purification
Rat brains (100 g) were homogenized by use of an Ultra Turrax homogenizer (Jahnke and Kunkel) in 0.02 M sodium phosphate buffer, pH 7.3 (400 ml), containing 6 mM NaN3 (buffer A). The homogenate was centrifuged at 100000 g for 45 min. The pellet was resuspended in 400 ml of buffer A and recentrifuged. This procedure was repeated five times to yield the washed pellet. After rehomogenization trypsin (1 ,tg/ml) was added and the suspension was incubated for 15 min at 4 'C. The reaction was stopped by addition of di-isopropyl fluorophosphate (1 mM). The solubilized enzyme was separated from the particulate matter by centrifugation at 100000 g for 90 min. The supernatant was applied to a Q-Sepharose column (2.6 cm x 16 cm) equilibrated with buffer A. After washing with 300 ml of buffer A the enzyme activity was eluted with a linear gradient of NaCl (0-0.3 M; total volume of 500 ml) in buffer A at a flow rate of 50 ml/h. The active fractions of the Q-Sepharose column were pooled and applied to a lentil lectin-Sepharose column (1 cm x 20 cm) at a flow rate of 20 ml/h. The column was washed with 10 vol. of buffer B (0.01 M diethyl malonate, pH 7.3/0.3 M NaCl/6 mM NaN3) and the enzyme activity was eluted with 0.5 M methyl-a-D-glucopyranoside in buffer B at a flow rate of 5 ml/h. Enzymecontaining fractions were pooled and concentrated in an Amicon ultrafiltration cell to a volume of 5 ml. This material was then subjected to gel filtration on a Sephadex G-200 column followed by hydrophobic interaction chromatography on a phenylSepharose column as described by O'Connor and O'Cuinn [20] .
Synthesis of pyroglutamic acid (pyroGlu) derivatives L-and D-pyroglutamyl hydroxamic acid were prepared by reacting L-and D-pyroglutamic acid ethyl ester with hydroxylamine in methanol as described [31] . Enzyme assays The activity of the TRH-degrading ectoenzyme was measured by the radiochemical assay described in [14] Labelling with 65Zn
The enzyme samples were incubated overnight at 4°C in 250 #1
of 0.1 M diethyl malonate/0.02 M NaCl, pH 7.3 containing 50 #Ci of 65ZnC12 (3.36 mCi/mg, Du Pont de Nemours). Then, they were subjected to h.p.l.c. analysis on a Pharmacia-LKB TSK-G-3000 SW gel filtration column. The material was eluted with 0.1 M diethyl malonate, pH 7.3, at a flow rate of0.2 ml/min. Fractions of 200 ,u1 were collected. Enzymic activity was assayed fluorimetrically after adding 2.5 ml of the fluorigenic substrate as described above, and radioactivity was measured using a Packard 500 CGD Prias y-counter (window limits 400 and 1600 keV).
Modffication by EDC Enzyme samples (20 1l) were diluted with 400 1l of reaction buffer (0.05 M Mes, pH 6.0, or 0.1 M potassium phosphate, pH 6.0). Then, 100 l1 of a freshly prepared solution of EDC (0.1 M) in the same buffer was added. In addition, some reaction mixtures contained 1 mM glycine methyl ester or 20 ,uM luteinizing-hormone-releasing hormone (LHRH) (Hoechst). After incubation at 20°C for the time periods indicated in the text, 2.5 ml of the fluorigenic substrate was added and the residual catalytic activity was determined as described above. For the reactivation experiments, 0.5 ml of 1 M hydroxylamine was added after incubation with the carbodiimide for 3 h at 20°C. The reaction mixture was then incubated at room temperature for an additional 60 min before substrate was added to determine the enzymic activity. Control reactions, without modifying reagent, were incubated in parallel for the 100 % values.
RESULTS
Inhibition by metal-complexing agents
The influence of metal-complexing agents on the enzymic activity of the TRH-degrading ectoenzyme is summarized in Table 1 . Without pre-incubation, only weak inhibition by submillimolar concentrations of EDTA was observed. After pre-incubation with the chelating agent for several hours, however, the enzymic activity was strongly reduced. Pre-incubation for 24 
The binding of Zn2+ ions
Metal analysis of the TRH-degrading enzyme by atomicabsorption spectrometry would require relatively large amounts of purified protein, which are difficult to obtain due to its very low abundance. Therefore we tried to detect the enzyme-bound zinc after exchanging it for its radioactive isotope 65Zn. For this purpose, an enzyme sample was incubated overnight at 4°C in the presence of a large excess of 65ZnCI2 and then subjected to gel-filtration chromatography on a TSK-3000 SW column. Fractions were screened for 65Zn content and enzyme activity. As shown in Figure 3(a) , the only peak in the u.v.-absorption profile (at 72 min) contained radioactivity as well as enzymic activity, thus indicating the binding of Zn2+ ions by the TRH-degrading enzyme. Unbound ZnCl2 (5 x 106 c.p.m.) was eluted from the column after 114 min (results not shown). To test the specificity of the zinc binding, the experiment was repeated using a partially purified enzyme sample. Again, a peak at 72 min contained both 65Zn and the entire enzymic activity (Figure 3b ). Despite the fact that large amounts of other proteins were present in the partially purified enzyme sample (note the different scales in the u.v. absorbance in Figure 3 ), only one small additional peak of radioactivity appeared at 49 min, whereas the major protein peaks eluting at 58 min and 64 min contained no 65Zn. Thus it seems unlikely that Zn2+ ions are unspecifically adsorbed to the TRH-degrading enzyme under the conditions employed. 90 min in phosphate buffer which leads to complete loss of the reagent's ability to inactivate the enzyme, whereas in Mes buffer its reactivity is only slightly affected.
After modification with carbodiimide, the enzymic activity could not be restored by incubation with 0.5 M hydroxylamine for 60 min (results not shown). This indicates that the observed inactivation is not due to the modification of a tyrosine residue, but is probably caused by the modification of a carboxyl group [34] . The presence of glycine methyl ester as a nucleophile had no influence on the rate of inactivation by EDC (Figure 4) , which is in agreement with the results obtained for the modification of the metalloprotease angiotensin-converting enzyme by cyclohexylmorpholinoethylcarbodiimide [35] .
When the enzyme was incubated with carbodiimide in the presence of20 ,uM LHRH, a non-cleavable, competitive inhibitor of the ectoenzyme, the rate of inactivation decreased significantly (Figure 4 ).
Inhibition by L-pyroglutamyl hydroxamic acid
The TRH-degrading ectoenzyme is weakly inhibited by LpyroGlu (Table 2) . Based on the assumption that this inhibition reflects an interaction of the TRH-cleavage product with the catalytic site of the enzyme, we tried to enhance the inhibitory potency by substituting the carboxyl group for a hydroxamic acid group, since hydroxamic acid derivatives of peptides or amino acids are known to inhibit various metalloproteases very effectively [36] . As expected, the resulting L-pyroglutamyl hydroxamic acid was a good inhibitor of the ectoenzyme. A Dixon plot revealed competitive inhibition with a K1 value of 160 ,uM ( Figure 5 ). In contrast, the enantiomer, D-pyroglutamyl hydroxamic acid had almost no inhibitory effect (Table 2) .
When L-pyroglutamyl hydroxamic acid was methylated at the hydroxamic nitrogen atom, the inhibitory potency decreased significantly and was furthermore reduced when the N-hydroxy group was methylated, or when the hydroxamic acid group was replaced by the non-chelating hydrazide or amide group (Table  2) .
DISCUSSION
The presented results clearly demonstrate that the TRHdegrading ectoenzyme is a metallopeptidase. Interestingly, two other brain ectoenzymes that are presumably involved in the degradation of neuropeptides, neutral endopeptidase ('enkephalinase') and aminopeptidase N, have also been identified as metallopeptidases [27, 37] .
Typical metalloproteases such as thermolysin [38] , angiotensin converting enzyme [28, 29] or neutral endopeptidase [27] are strongly, and almost immediately, inhibited by low concentrations of EDTA. The TRH-degrading ectoenzyme, in contrast, is effectively inhibited by micromolar concentrations of EDTA only when incubated for prolonged periods of time. A timedependent inhibition of metalloenzymes by chelating agents is not unprecedented, but the inhibition has required several hours of incubation in only very few cases. A most unusual example is the inhibition of the 'low-molecular-weight protease' from Astacus fluviatilis by EDTA which requires about 6 days of incubation to reach its half-maximal value [39] . Therefore it is understandable that the zinc-catalysed mechanism of this enzyme remained hidden for a long time.
The TRH-degrading ectoenzyme and the 'low-molecularweight protease' are also inhibited by 1,10-phenanthroline in a time-dependent manner. In contrast, the inhibition of the 'lowmolecular-weight protease' by the non-chelating analogue 1,7- phenanthroline [39] , as well as the inhibition of the TRHdegrading ectoenzyme by 1,7-phenanthroline and 4,7-phenanthroline (Table 1) , are not time-dependent and are probably due to unspecific hydrophobic interactions of the enzyme with the aromatic structures of these compounds. This interpretation is supported by the observation that the TRH-degrading enzyme interacts strongly with phenyl-Sepharose, a distinctive property that has been effectively exploited for purifying the TRHdegrading ectoenzyme [20] . This feature may also contribute to the inhibition of the TRH-degrading enzyme by a-N-(l -carboxy-2-phenylethyl)-1-benzylhistidinyl-,/-naphthylamide, the only substrate-related inhibitor described as yet [40] .
Like the other metalloproteases such as thermolysin [38] or neutral endopeptidase [27] , the TRH-degrading ectoenzyme is also inhibited by NaCN [41] , whereas the inhibition by other transition metal ions is also due to the exchange of the catalytic Zn2+ ion.
The activity of the TRH-degrading ectoenzyme is significantly increased in the presence of Co2+. The same effect is also observed with other zinc-proteases [28, 37, 42, 43] . The active sites of almost all metalloproteases contain a glutamic acid residue, which serves as proton acceptor for the hydrolysis of the substrate [44] . Modification of this residue by carbodiimides leads to inactivation of the enzymes [35, [45] [46] [47] [48] . Under appropriate conditions, the TRH-degrading ectoenzyme is also inactivated by EDC. The rate of inactivation is significantly decreased in the presence of LHRH, a competitive inhibitor of the TRH-degrading serum enzyme [21] and the TRH-degrading ectoenzyme [20] . The protective effect of LHRH therefore suggests that the modified carboxyl group is part of the catalytic centre.
Besides the glutamic acid, the active sites of metalloproteases usually contain a tyrosine residue and basic amino acids which are essential for their activity [35,46-48a] . The presence of tyrosine, histidine and arginine residues as catalytically important elements of the TRH-degrading ectoenzyme has been clearly demonstrated by O'Connor and O'Cuinn [30] . Taken together, the modification studies are in full agreement with the classification of this enzyme as a metalloenzyme.
Based on the zinc-catalysed reaction mechanism, inhibition of the TRH-degrading enzyme by L-pyroglutamyl hydroxamic acid could be predicted and demonstrated. X-ray crystallography of a thermolysin-L-leucyl hydroxamic acid complex revealed that the essential Zn2+ ion is complexed in a bidentate fashion by both hydroxamic oxygen atoms of the inhibitor [49] . Hence, alkylation of the N-hydroxyl group reduces the metal-chelating ability of the compound and consequently also its inhibitory potency [50] .
Yet, methylation at the hydroxamic nitrogen atom also decreases the inhibitory efficacy, perhaps due to sterical hindrance [50] . The same observations were made for the inhibition of the TRHdegrading ectoenzyme by L-pyroglutamyl hydroxamic acid and the methylated analogues. There is hope that the identification of the TRH-degrading ectoenzyme as a metallopeptidase may provide the basis for the rational design and synthesis of site-directed inhibitors which may be invaluable tools with which to further our understanding on the biological function of the TRH-degrading ectoenzyme and its possible role as a terminator of TRH signals.
